Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota. more
Time Frame | ANIP | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.67% | -2.27% | -0.57% |
1-Month Return | -5.42% | -3.96% | 1.21% |
3-Month Return | -3.28% | -9.7% | 7.57% |
6-Month Return | -10.52% | -3.37% | 11.45% |
1-Year Return | 7.61% | 3.71% | 28.48% |
3-Year Return | 30.27% | 3.8% | 29.52% |
5-Year Return | -7.37% | 39.78% | 90.66% |
10-Year Return | 5.26% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 206.55M | 208.47M | 216.14M | 316.38M | 486.82M | [{"date":"2019-12-31","value":42.43,"profit":true},{"date":"2020-12-31","value":42.82,"profit":true},{"date":"2021-12-31","value":44.4,"profit":true},{"date":"2022-12-31","value":64.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 63.15M | 87.16M | 100.61M | 138.78M | 181.51M | [{"date":"2019-12-31","value":34.79,"profit":true},{"date":"2020-12-31","value":48.02,"profit":true},{"date":"2021-12-31","value":55.43,"profit":true},{"date":"2022-12-31","value":76.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 143.39M | 121.32M | 115.53M | 177.60M | 305.30M | [{"date":"2019-12-31","value":46.97,"profit":true},{"date":"2020-12-31","value":39.74,"profit":true},{"date":"2021-12-31","value":37.84,"profit":true},{"date":"2022-12-31","value":58.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 69.42% | 58.19% | 53.45% | 56.13% | 62.71% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":83.82,"profit":true},{"date":"2021-12-31","value":76.99,"profit":true},{"date":"2022-12-31","value":80.86,"profit":true},{"date":"2023-12-31","value":90.34,"profit":true}] |
Operating Expenses | 126.97M | 136.89M | 143.69M | 203.33M | 258.33M | [{"date":"2019-12-31","value":49.15,"profit":true},{"date":"2020-12-31","value":52.99,"profit":true},{"date":"2021-12-31","value":55.62,"profit":true},{"date":"2022-12-31","value":78.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 16.35M | (16.06M) | (32.51M) | (25.06M) | 46.97M | [{"date":"2019-12-31","value":34.81,"profit":true},{"date":"2020-12-31","value":-34.2,"profit":false},{"date":"2021-12-31","value":-69.22,"profit":false},{"date":"2022-12-31","value":-53.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (26.16M) | (19.40M) | (28.19M) | (55.43M) | (55.80M) | [{"date":"2019-12-31","value":-2616000000,"profit":false},{"date":"2020-12-31","value":-1939800000,"profit":false},{"date":"2021-12-31","value":-2818700000,"profit":false},{"date":"2022-12-31","value":-5543400000,"profit":false},{"date":"2023-12-31","value":-5579900000,"profit":false}] |
Pre-Tax Income | 3.16M | (25.96M) | (56.06M) | (62.66M) | 19.87M | [{"date":"2019-12-31","value":15.89,"profit":true},{"date":"2020-12-31","value":-130.65,"profit":false},{"date":"2021-12-31","value":-282.1,"profit":false},{"date":"2022-12-31","value":-315.34,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | (2.94M) | (3.41M) | (13.46M) | (14.77M) | 1.09M | [{"date":"2019-12-31","value":-268.71,"profit":false},{"date":"2020-12-31","value":-312.35,"profit":false},{"date":"2021-12-31","value":-1231.02,"profit":false},{"date":"2022-12-31","value":-1351.24,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 6.09M | (22.55M) | (42.60M) | (47.90M) | 18.78M | [{"date":"2019-12-31","value":32.45,"profit":true},{"date":"2020-12-31","value":-120.07,"profit":false},{"date":"2021-12-31","value":-226.87,"profit":false},{"date":"2022-12-31","value":-255.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 6.09M | (22.55M) | (42.60M) | (47.90M) | 13.38M | [{"date":"2019-12-31","value":45.54,"profit":true},{"date":"2020-12-31","value":-168.51,"profit":false},{"date":"2021-12-31","value":-318.38,"profit":false},{"date":"2022-12-31","value":-357.94,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 6.09M | (22.55M) | (42.60M) | (47.90M) | 18.78M | [{"date":"2019-12-31","value":32.45,"profit":true},{"date":"2020-12-31","value":-120.07,"profit":false},{"date":"2021-12-31","value":-226.87,"profit":false},{"date":"2022-12-31","value":-255.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 5.05 | 3.50 | 3.26 | 1.41 | 4.72 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":69.31,"profit":true},{"date":"2021-12-31","value":64.55,"profit":true},{"date":"2022-12-31","value":27.92,"profit":true},{"date":"2023-12-31","value":93.47,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ANIP | |
---|---|
Cash Ratio | 0.81 |
Current Ratio | 2.74 |
Quick Ratio | 1.97 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ANIP | |
---|---|
ROA (LTM) | 1.25% |
ROE (LTM) | -1.60% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ANIP | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.67 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.33 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ANIP | |
---|---|
Trailing PE | NM |
Forward PE | 9.14 |
P/S (TTM) | 2.24 |
P/B | 2.93 |
Price/FCF | 177 |
EV/R | 3.03 |
EV/Ebitda | 24.03 |
PEG | 1.06 |
ANI Pharmaceuticals Inc (ANIP) share price today is $56.59
Yes, Indians can buy shares of ANI Pharmaceuticals Inc (ANIP) on Vested. To buy ANI Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ANIP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ANI Pharmaceuticals Inc (ANIP) via the Vested app. You can start investing in ANI Pharmaceuticals Inc (ANIP) with a minimum investment of $1.
You can invest in shares of ANI Pharmaceuticals Inc (ANIP) via Vested in three simple steps:
The 52-week high price of ANI Pharmaceuticals Inc (ANIP) is $70.81. The 52-week low price of ANI Pharmaceuticals Inc (ANIP) is $51.88.
The price-to-earnings (P/E) ratio of ANI Pharmaceuticals Inc (ANIP) is
The price-to-book (P/B) ratio of ANI Pharmaceuticals Inc (ANIP) is 2.93
The dividend yield of ANI Pharmaceuticals Inc (ANIP) is 0.00%
The market capitalization of ANI Pharmaceuticals Inc (ANIP) is $1.19B
The stock symbol (or ticker) of ANI Pharmaceuticals Inc is ANIP